NUP192 antibodies are indispensable for:
Structural Studies: Cryo-EM and immunoprecipitation (IP) reveal NUP192’s spatial arrangement within the NPC. For example, near-atomic resolution maps (3.73 Å) show NUP192-NUP188 complexes forming the IR monomer’s middle layer .
Functional Analysis: Mutagenesis studies using antibodies identify residues critical for interactions (e.g., Phe1735 and Ile1730 in NUP192’s TAIL domain, which disrupt Nic96 binding) .
Disease Research: While not directly linked to autoimmune conditions like anti-NUP62 or anti-gp210 syndromes , NUP192 dysregulation may contribute to NPC-related pathologies.
NUP192 binds Nic96’s R2 region, a interaction dispensable for CNT incorporation but essential for mRNA/ribosomal export .
Deletion of NUP192’s TAIL domain causes severe growth defects in S. cerevisiae, highlighting its role in CNT positioning .
NUP192 and NUP188 exhibit FG-repeat binding akin to nuclear transport receptors, suggesting a role in modulating transport efficiency .
Structural flexibility allows NUP192 to adapt during transport, as shown by its dynamic association with Nic96 and CNT .
Antibody Validation: Specificity is confirmed via siRNA knockdown (e.g., loss of NUP192 signal in ΔTAIL mutants) .
Assay Compatibility: Used in Western blot (WB), IP, and immunofluorescence (IF) .
Research gaps include:
Mechanistic Insights: How NUP192’s FG-repeat binding regulates transport.
Therapeutic Potential: Targeting NUP192 in diseases with NPC dysfunction (e.g., cancer, viral infections).
KEGG: sce:YJL039C
STRING: 4932.YJL039C
NUP192 is an evolutionarily conserved nucleoporin and a major component of the nuclear pore complex (NPC). It functions as part of the adaptor nucleoporin complex (ANC) that links the NPC coat with the central transport channel. NUP192 is one of the largest yeast nucleoporins and is essential for cell growth . In yeast, it has a preferential location at the inner site of the nuclear membrane, approximately 60 ± 15 nm from the central plane of the pore .
Functionally, NUP192 serves as an interaction platform within the ANC, binding to multiple nucleoporins through distinct binding sites. While not directly involved in nuclear import or mRNA export, its proper function is essential for maintaining the structural integrity of the NPC. Temperature-sensitive mutations in NUP192 can disrupt the association of other nucleoporins (such as Nup49) with nuclear pores .
NUP192 possesses a large N-terminal domain (NTD) and a C-terminal tail (TAIL) domain with distinct functions:
The N-terminal domain (~110 kDa) has a ring-shaped architecture composed of HEAT and Armadillo (ARM) repeats. This domain forms an open ring structure with two rigid halves connected by a flexible hinge .
The C-terminal tail domain contains binding sites for other nucleoporins, including Nic96.
Research has identified specific interaction regions:
A conserved patch on NUP192 binds to an unstructured segment in Nup53
The C-terminal tail region binds to a putative helical fragment in Nic96
The Nup53 segment that binds NUP192 resembles a classical nuclear localization sequence
Mutation experiments showed that disrupting the TAIL domain resulted in substantial growth defects at all temperatures and significant mRNA and ribosomal export defects. This suggests that while this domain is not essential for NPC localization, it is critical for proper NPC function .
For optimal detection of NUP192 in cellular samples, consider these methodological approaches:
Immunofluorescence microscopy:
Fix cells with 4% paraformaldehyde in DPBS buffer (20 minutes)
Permeabilize with 0.1% Triton X-100 (20 minutes at room temperature)
Block with 2% normal serum in DPBS with 1% BSA
Use antibodies specific to NUP192 (similar to approaches used for other nucleoporins)
Western blotting:
Separate nuclear envelope fractions or whole cell lysates on SDS-PAGE
Transfer to nitrocellulose or PVDF membranes
Block with 5% non-fat dry milk or BSA
Use primary antibodies specific to NUP192
Detect with appropriate secondary antibodies conjugated to HRP or fluorophores
Cellular fractionation for enrichment:
Isolate nuclei from cell cultures
Fractionate into "nuclear insoluble" (nuclear envelope, NPC, and chromatin-bound) and "nuclear soluble" components to better analyze NPC-associated proteins
When working with NUP192 antibodies, rigorous controls are essential:
Positive controls:
Cell lines known to express NUP192
Recombinant NUP192 protein or fragments
GFP-tagged NUP192 expressing cells
Negative controls:
siRNA knockdown of NUP192 (for validation of antibody specificity)
Pre-immune serum (for polyclonal antibodies)
Isotype-matched control antibodies (for monoclonals)
Secondary antibody-only controls
Cross-reactivity assessment:
Test the antibody against related proteins, particularly Nup188, which shares structural and functional similarities with NUP192
Validate with Western blotting to confirm appropriate molecular weight detection
For knockout validation, a complete NUP192 knockout is likely lethal as it's essential for cell growth , so conditional or partial knockdowns are more appropriate for validation experiments.
NUP192 establishes multiple interactions within the nuclear pore complex that are critical for NPC assembly and function:
Key interaction partners:
Nic96: NUP192 binds to Nic96 through its C-terminal tail domain. The interaction involves specific residues (Phe1735 and Ile1730 in the thermophilic fungus Chaetomium thermophilum) located in a hydrophobic pocket at the bottom of the NUP192 molecule .
Nup53: NUP192 binds to an unstructured segment in Nup53 through a conserved patch. Interestingly, this binding segment resembles a classical nuclear localization sequence .
Nup192 is also associated with Nic96p, as demonstrated by affinity purification experiments .
Functional significance of interactions:
Mutation studies show that disrupting the NUP192-Nic96 interaction causes significant growth and mRNA export defects, indicating this interaction is required for proper NPC function .
While these interactions are important for NPC function, they appear dispensable for NPC localization, suggesting that NUP192 has additional nucleoporin interaction partners that anchor it to the NPC .
To investigate NUP192 interactions, researchers can employ these methodological approaches:
In vitro binding assays:
Recombinant protein pull-down assays using purified components
Surface plasmon resonance (SPR) to measure binding kinetics
Isothermal titration calorimetry (ITC) for thermodynamic parameters
Cellular interaction studies:
Co-immunoprecipitation from cellular extracts
Proximity labeling approaches (BioID, APEX)
Fluorescence resonance energy transfer (FRET)
Mutation analysis:
Alanine scanning mutagenesis to identify critical binding residues
Domain deletion constructs to map interaction regions
Structural biology approaches:
X-ray crystallography of NUP192 in complex with binding partners
Cryo-electron microscopy of larger assemblies
While the search results don't specifically mention autoantibodies against NUP192, they do provide relevant information about antibodies against other nuclear pore complex proteins in autoimmune diseases:
Related nucleoporin autoantibodies:
Approximately 25% of patients with primary biliary cirrhosis (PBC) have antibodies targeting proteins of the nuclear pore complex (NPC) .
Autoantibodies against the integral membrane glycoprotein gp210 and nucleoporin p62 appear to be highly specific for PBC .
Anti-gp210 antibodies were reported in 17.9% (210/1,175) of patients with PBC in a multicenter study .
Anti-nup62 antibodies have been reported in 22-32% of patients with PBC and may also occur in systemic lupus erythematosus (SLE) and Sjögren's syndrome .
Clinical significance:
The presence of anti-NPC antibodies in PBC may identify patients who progress faster and experience a more unfavorable clinical course .
Sustained antibody response to gp210 identified patients at higher risk for progression to end-stage liver disease .
Persistence after treatment:
Anti-gp210 autoantibodies persist in the majority of patients after receiving liver transplants, though titers may decrease due to immunosuppression .
Based on these findings, researchers investigating potential NUP192 autoantibodies should consider screening sera from patients with autoimmune liver diseases and other systemic autoimmune conditions.
For optimal immunofluorescence detection of NUP192 at the nuclear pore complex, consider these methodological details:
Fixation and permeabilization:
Use 4% paraformaldehyde in DPBS buffer for 20 minutes
Permeabilize with 0.1% Triton X-100 for 20 minutes at room temperature
These conditions are effective for other nucleoporins and are likely suitable for NUP192
Blocking and antibody incubation:
Block with 2% normal goat serum in DPBS with 1% BSA
Incubate with primary antibody overnight at 4°C for optimal signal-to-noise ratio
Use appropriate fluorophore-conjugated secondary antibodies
Expected staining pattern:
NUP192 should display a punctate nuclear rim staining pattern similar to other nucleoporins
Co-staining with the widely used mAb414 antibody (which recognizes FG-repeat-containing nucleoporins) can serve as a control for NPC staining
Imaging considerations:
Use confocal microscopy for optimal visualization of the nuclear envelope
Consider super-resolution microscopy techniques (STED, STORM, PALM) for detailed localization studies
Validating the specificity of a NUP192 antibody requires multiple complementary approaches:
Experimental validation methods:
Western blotting: The antibody should detect a single band at the expected molecular weight (~192 kDa)
RNAi knockdown: Signal should be reduced proportionally to knockdown efficiency
Immunofluorescence pattern: Should show characteristic nuclear rim staining consistent with NPC localization
Peptide competition: Pre-incubation with the immunizing peptide should abolish specific signal
Cross-species reactivity testing: Evaluate conservation-based predicted reactivity
Potential cross-reactivity concerns:
Test for cross-reactivity with Nup188, which shares structural and functional similarities with NUP192
Evaluate specificity in cell lines with varying expression levels of NUP192
Reference standards:
Compare results with published localization data or GFP-tagged NUP192 expression
Consider using the automated NuRIM image-processing pipeline that has been used to quantify nucleoporin intensities at the nuclear envelope
For investigating NUP192 dynamics in live cells, consider these methodological approaches:
Fluorescent protein tagging:
GFP-tagging of NUP192 has been successfully performed in yeast to confirm its localization to nuclear pores
For mammalian cells, consider using mNeonGreen or HaloTag for improved brightness and photostability
Careful validation is needed to ensure the tag doesn't disrupt protein function
Photobleaching techniques:
Fluorescence Recovery After Photobleaching (FRAP) to measure turnover rates
Inverse FRAP (iFRAP) to monitor dissociation kinetics from the NPC
Live cell experimental design considerations:
Use temperature control to maintain physiological conditions
Consider using the thermophilic fungus Chaetomium thermophilum NUP192, which displays improved biochemical robustness
Time-lapse imaging at different cell cycle stages to capture potential dynamics
Data analysis approaches:
Quantify recovery half-times and mobile/immobile fractions
Compare dynamics between wild-type and mutant forms
Analyze changes in response to cellular stresses or transport inhibitors
Accurately determining NUP192 stoichiometry within the NPC requires specialized techniques:
Quantitative imaging approaches:
The NuRIM automated image-processing pipeline has been used to measure the relative abundance of nucleoporins at the nuclear envelope
Single molecule counting approaches using photoactivatable fluorescent proteins
Quantitative mass spectrometry of isolated NPCs
Recent findings on nucleoporin stoichiometry:
Research has shown that Nup188 and Nup192 likely form a paralog pair that originated from an ancient gene duplication event (~800 Mya)
When NUP188 is deleted, introduction of an extra copy of NUP192-yEGFP results in >50% increase in NPC abundance, suggesting Nup192 can partially occupy empty Nup188 sites
This indicates remarkable compositional plasticity in the NPC
Methodological considerations:
Ensure linear detection range of your imaging system
Use appropriate fluorescent standards for calibration
Consider the impact of fluorescent tags on protein incorporation
Account for potential variations in NPC composition across different cell types and conditions
| Nucleoporin | Approximate copies per NPC (Yeast) | Notes on quantification |
|---|---|---|
| Nup192 | ~16 copies | Can increase when Nup188 is deleted and extra Nup192 is expressed |
| Nup188 | ~16 copies | Forms paralog pair with Nup192 |
| Nic96 | ~32 copies | Higher abundance than Y-complex members |
When working with NUP192 antibodies, researchers may encounter these challenges:
High background in immunofluorescence:
Problem: Non-specific nuclear envelope staining
Solution: Optimize blocking (try 5% BSA or normal serum), increase washing steps, reduce antibody concentration, or try a different antibody clone
Weak or absent signal:
Problem: Insufficient detection of NUP192
Solution:
Verify protein expression in your sample
Test different fixation methods (PFA vs. methanol)
Optimize antigen retrieval if using fixed tissues
Use signal amplification methods (TSA)
Multiple bands in Western blot:
Problem: Non-specific bands or degradation products
Solution:
Use freshly prepared samples with protease inhibitors
Optimize lysate preparation by including nuclear envelope enrichment steps
Consider using gradient gels for better resolution of high molecular weight proteins
Inconsistent results between experiments:
Problem: Variable staining patterns or intensities
Solution:
Standardize cell culture conditions and fixation protocols
Include positive controls in each experiment
Consider batch variability in antibodies and prepare larger working aliquots
For specific technical challenges unique to NUP192, researchers should note that due to its large size (~192 kDa), extraction and detection may require special considerations for protein transfer and detection in Western blotting.
Recent advances in active learning can enhance experimental efficiency when working with NUP192 antibodies:
Application of active learning to antibody development:
Active learning reduces costs by starting with a small labeled subset of data and iteratively expanding the labeled dataset
In antibody-antigen interactions, this approach can significantly improve experimental efficiency in library-on-library settings
Practical implementation for NUP192 antibody optimization:
Begin with small-scale validation experiments to identify promising antibody candidates
Use initial results to guide selection of additional validation methods
Implement an iterative optimization strategy:
Test a small panel of conditions
Analyze results
Use findings to inform next experimental design
Repeat with refined parameters
Performance benefits:
Active learning strategies have been shown to reduce the number of required experimental variants by up to 35%
These approaches can accelerate the learning process by significantly reducing the number of experimental iterations needed
Apply similar principles to optimize immunostaining conditions, fixation protocols, and detection methods